113 related articles for article (PubMed ID: 31068339)
1. Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization.
Le Joncour V; Filppu P; Hyvönen M; Holopainen M; Turunen SP; Sihto H; Burghardt I; Joensuu H; Tynninen O; Jääskeläinen J; Weller M; Lehti K; Käkelä R; Laakkonen P
EMBO Mol Med; 2019 Jun; 11(6):. PubMed ID: 31068339
[TBL] [Abstract][Full Text] [Related]
2. Novel target for peptide-based imaging and treatment of brain tumors.
Hyvönen M; Enbäck J; Huhtala T; Lammi J; Sihto H; Weisell J; Joensuu H; Rosenthal-Aizman K; El-Andaloussi S; Langel U; Närvänen A; Bergers G; Laakkonen P
Mol Cancer Ther; 2014 Apr; 13(4):996-1007. PubMed ID: 24493698
[TBL] [Abstract][Full Text] [Related]
3. CAR T cells for brain tumors: Lessons learned and road ahead.
Akhavan D; Alizadeh D; Wang D; Weist MR; Shepphird JK; Brown CE
Immunol Rev; 2019 Jul; 290(1):60-84. PubMed ID: 31355493
[TBL] [Abstract][Full Text] [Related]
4. Repurposing Clemastine to Target Glioblastoma Cell Stemness.
Sun MA; Yang R; Liu H; Wang W; Song X; Hu B; Reynolds N; Roso K; Chen LH; Greer PK; Keir ST; McLendon RE; Cheng SY; Bigner DD; Ashley DM; Pirozzi CJ; He Y
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760589
[TBL] [Abstract][Full Text] [Related]
5. The origin of brain malignancies at the blood-brain barrier.
McDonald B; Barth K; Schmidt MHH
Cell Mol Life Sci; 2023 Sep; 80(10):282. PubMed ID: 37688612
[TBL] [Abstract][Full Text] [Related]
6. PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells.
Denisova OV; Merisaari J; Huhtaniemi R; Qiao X; Yetukuri L; Jumppanen M; Kaur A; Pääkkönen M; von Schantz-Fant С; Ohlmeyer M; Wennerberg K; Kauko O; Koch R; Aittokallio T; Taipale M; Westermarck J
Mol Oncol; 2023 Sep; 17(9):1803-1820. PubMed ID: 37458534
[TBL] [Abstract][Full Text] [Related]
7. Targeting fatty acid oxidation via Acyl-CoA binding protein hinders glioblastoma invasion.
Duman C; Di Marco B; Nevedomskaya E; Ulug B; Lesche R; Christian S; Alfonso J
Cell Death Dis; 2023 Apr; 14(4):296. PubMed ID: 37120445
[TBL] [Abstract][Full Text] [Related]
8. Interactions of Nanoscale Self-Assembled Peptide-Based Assemblies with Glioblastoma Cell Models and Spheroids.
Lebedenko CG; Murray ME; Goncalves BG; Perez DS; Lambo DJ; Banerjee IA
ACS Omega; 2023 Apr; 8(13):12124-12143. PubMed ID: 37033803
[TBL] [Abstract][Full Text] [Related]
9. Shaping the brain vasculature in development and disease in the single-cell era.
Wälchli T; Bisschop J; Carmeliet P; Zadeh G; Monnier PP; De Bock K; Radovanovic I
Nat Rev Neurosci; 2023 May; 24(5):271-298. PubMed ID: 36941369
[TBL] [Abstract][Full Text] [Related]
10. Combining precision oncology and immunotherapy by targeting the MALT1 protease.
Mempel TR; Krappmann D
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36270731
[TBL] [Abstract][Full Text] [Related]
11. Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells.
Denisova OV; Merisaari J; Kaur A; Yetukuri L; Jumppanen M; von Schantz-Fant C; Ohlmeyer M; Wennerberg K; Aittokallio T; Taipale M; Westermarck J
Sci Rep; 2022 Aug; 12(1):13796. PubMed ID: 35963891
[TBL] [Abstract][Full Text] [Related]
12. Lucanthone Targets Lysosomes to Perturb Glioma Proliferation, Chemoresistance and Stemness, and Slows Tumor Growth
Radin DP; Smith G; Moushiaveshi V; Wolf A; Bases R; Tsirka SE
Front Oncol; 2022; 12():852940. PubMed ID: 35494072
[TBL] [Abstract][Full Text] [Related]
13. Bivalent EGFR-Targeting DARPin-MMAE Conjugates.
Karsten L; Janson N; Le Joncour V; Alam S; Müller B; Tanjore Ramanathan J; Laakkonen P; Sewald N; Müller KM
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269611
[TBL] [Abstract][Full Text] [Related]
14. The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies.
Berg AL; Rowson-Hodel A; Hu M; Keeling M; Wu H; VanderVorst K; Chen JJ; Hatakeyama J; Jilek J; Dreyer CA; Wheeler MR; Yu AM; Li Y; Carraway KL
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205696
[TBL] [Abstract][Full Text] [Related]
15. Circumventing Drug Treatment? Intrinsic Lethal Effects of Polyethyleneimine (PEI)-Functionalized Nanoparticles on Glioblastoma Cells Cultured in Stem Cell Conditions.
Prabhakar N; Merisaari J; Le Joncour V; Peurla M; Karaman DŞ; Casals E; Laakkonen P; Westermarck J; Rosenholm JM
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071918
[TBL] [Abstract][Full Text] [Related]
16. OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs.
Kast RE; Halatsch ME; Rosell R
Cells; 2021 May; 10(5):. PubMed ID: 34068720
[TBL] [Abstract][Full Text] [Related]
17. CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity.
Filppu P; Tanjore Ramanathan J; Granberg KJ; Gucciardo E; Haapasalo H; Lehti K; Nykter M; Le Joncour V; Laakkonen P
JCI Insight; 2021 May; 6(9):. PubMed ID: 33986188
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic and macrophage-based therapeutic strategies for glioma immunotherapy.
Ishikawa E; Miyazaki T; Takano S; Akutsu H
Brain Tumor Pathol; 2021 Jul; 38(3):149-155. PubMed ID: 33977360
[TBL] [Abstract][Full Text] [Related]
19. Greater epithelial ridge cells are the principal organoid-forming progenitors of the mouse cochlea.
Kubota M; Scheibinger M; Jan TA; Heller S
Cell Rep; 2021 Jan; 34(3):108646. PubMed ID: 33472062
[TBL] [Abstract][Full Text] [Related]
20. Endothelial-Tumor Cell Interaction in Brain and CNS Malignancies.
Peleli M; Moustakas A; Papapetropoulos A
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
